Annovis Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Annovis Bio
ANVS Stock  USD 2.70  0.11  3.91%   
Annovis Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Annovis Bio's valuation are provided below:
Market Capitalization
59.8 M
Earnings Share
(2.10)
There are over one hundred thirteen available fundamental signals for Annovis Bio, which can be analyzed over time and compared to other ratios. All traders should validate Annovis Bio's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Annovis Bio Total Revenue

185,175

Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 2 M, Selling General Administrative of 8.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.22. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.
  
Build AI portfolio with Annovis Stock
Check out the analysis of Annovis Bio Correlation against competitors.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Annovis Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15 M16 M10.2 M
Slightly volatile
Other Current Liabilities1.2 M1.8 M955.7 K
Slightly volatile
Total Current Liabilities3.1 M4.5 M2.2 M
Slightly volatile
Accounts Payable1.5 M2.1 M1.2 M
Pretty Stable
Cash9.6 M12.1 M7.3 M
Slightly volatile
Net Receivables628.5 K661.6 K978.7 K
Slightly volatile
Other Current Assets3.7 M3.9 M45.3 M
Very volatile
Other Stockholder Equity174.1 M165.8 M49.9 M
Slightly volatile
Total Liabilities6.4 M5.3 M6.2 M
Pretty Stable
Total Current Assets13.1 M16 M9.5 M
Slightly volatile
Intangible Assets1.1 M1.1 M1.2 M
Slightly volatile
Common Stock1.2 K1.3 K125.7 K
Slightly volatile
Property Plant Equipment55.7 K58.6 K95.2 K
Slightly volatile
Other Assets4.1 B3.9 B1.5 B
Slightly volatile
Good Will4.2 M3.8 M4.3 M
Slightly volatile
Cash And Short Term Investments13.6 M12.1 M7.5 M
Slightly volatile
Common Stock Total Equity978932359
Slightly volatile
Common Stock Shares Outstanding8.1 M14.1 M6.6 M
Slightly volatile
Liabilities And Stockholders Equity15.9 M16 M8.8 M
Slightly volatile
Non Current Liabilities Total630.1 K663.3 K5.3 M
Slightly volatile
Capital Surpluse88.4 M84.2 M28.7 M
Slightly volatile
Capital Stock1.7 K1.6 K494
Slightly volatile
Short and Long Term Debt Total399.8 K449.8 K491 K
Slightly volatile
Other Liabilities84.8 K95.4 K104.1 K
Slightly volatile
Long Term Debt399.8 K449.8 K491 K
Slightly volatile
Long Term Debt Total399.8 K449.8 K491 K
Slightly volatile
Deferred Long Term Liabilities295.7 K332.6 K363.1 K
Slightly volatile
Short Term Investments8.4 B9.5 B10.4 B
Slightly volatile

Annovis Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative8.1 M7.7 M3.2 M
Slightly volatile
Depreciation And Amortization1.091.151.7 M
Pretty Stable
Other Operating Expenses16.7 M30.7 M10.2 M
Slightly volatile
Research Development12.1 M23 M7.4 M
Slightly volatile
Interest Income275.2 K381.6 K140 K
Slightly volatile
Non Operating Income Net Other31.4 K33.1 K744.2 K
Slightly volatile
Selling And Marketing Expenses80 K90 K98.2 K
Slightly volatile

Annovis Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock56.4 M53.8 M19 M
Slightly volatile
Net Borrowings640 K609.5 K470.6 K
Slightly volatile
Depreciation140.9 K148.3 K563.1 K
Slightly volatile
Total Cash From Financing Activities32.2 B30.7 B5.3 B
Slightly volatile
End Period Cash Flow12.7 B12.1 B2.1 B
Slightly volatile
Stock Based Compensation4.6 B4.4 B759 M
Slightly volatile
Begin Period Cash Flow6.9 B6.6 B1.1 B
Slightly volatile
Issuance Of Capital Stock16.8 M21.5 M8.6 M
Slightly volatile
Cash And Cash Equivalents Changes25.1 M43.3 M18.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Average Payables1.4 M1.6 M1.3 M
Slightly volatile
Cash Per Share1.230.780.8766
Slightly volatile
Income Quality0.570.80.7398
Slightly volatile
Current Ratio5.643.234.1411
Slightly volatile
Average Receivables294 K330.8 K361.1 K
Slightly volatile
Interest Debt Per Share0.130.140.4963
Pretty Stable
Debt To Assets0.360.40.4395
Slightly volatile
Ebt Per Ebit0.740.830.7483
Slightly volatile
Effective Tax Rate1.0E-42.0E-42.0E-4
Slightly volatile
Quick Ratio3.924.1325.9064
Very volatile
Cash Ratio2.322.453.6788
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9824
Slightly volatile
Debt Ratio0.360.40.4395
Slightly volatile

Annovis Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap107.3 M120.7 M131.7 M
Slightly volatile
Enterprise Value70.7 M79.5 M86.8 M
Slightly volatile

Annovis Fundamental Market Drivers

Annovis Upcoming Events

1st of April 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue10.3 K9.8 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY